Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders | Psychedelic Invest
SARASOTA, FL, Nov. 18, 2024 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on developing novel